Pfizer Inc.
PFE
$26.10
$0.160.62%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 21.92% | 31.20% | 2.13% | -19.51% | -40.02% |
Total Other Revenue | -- | -- | -- | -- | -13.85% |
Total Revenue | 21.92% | 31.20% | 2.12% | -19.51% | -40.02% |
Cost of Revenue | -20.97% | -45.30% | -9.90% | -36.04% | -23.31% |
Gross Profit | 64.59% | 179.70% | 5.84% | -13.80% | -50.70% |
SG&A Expenses | 14.75% | 0.13% | 6.69% | 2.20% | 7.14% |
Depreciation & Amortization | 7.26% | 11.28% | 10.39% | 18.59% | 12.02% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -3.84% | -25.28% | 0.87% | -12.46% | -14.05% |
Operating Income | 392.75% | 344.64% | 6.71% | -31.45% | -115.52% |
Income Before Tax | 99.76% | 240.66% | -104.54% | -45.44% | -178.95% |
Income Tax Expenses | 47.04% | 124.27% | -88.73% | -59.02% | -445.65% |
Earnings from Continuing Operations | 112.33% | 287.65% | -98.68% | -43.69% | -166.68% |
Earnings from Discontinued Operations | 126.92% | -166.67% | 950.00% | -600.00% | -1,400.00% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 11.11% | -33.33% | 36.36% | 38.46% | -12.50% |
Net Income | 112.17% | 287.45% | -98.24% | -43.80% | -167.46% |
EBIT | 392.75% | 344.64% | 6.71% | -31.45% | -115.52% |
EBITDA | 558.06% | 1,012.64% | 7.94% | -22.75% | -90.92% |
EPS Basic | 112.12% | 286.75% | -98.25% | -44.03% | -167.08% |
Normalized Basic EPS | 470.04% | 329.71% | -14.81% | -44.10% | -112.49% |
EPS Diluted | 111.86% | 286.75% | -98.24% | -43.40% | -169.03% |
Normalized Diluted EPS | 467.70% | 328.15% | -14.23% | -43.57% | -112.77% |
Average Basic Shares Outstanding | 0.35% | 0.37% | 0.35% | 0.41% | 0.57% |
Average Diluted Shares Outstanding | 0.99% | 1.04% | -0.30% | -0.52% | -1.67% |
Dividend Per Share | 2.44% | 2.44% | 2.44% | 2.44% | 2.50% |
Payout Ratio | 9.45% | 1.55% | 57.35% | 0.83% | -2.53% |